Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,583,636
-$14,573,559 QoQ
Shares Held
2,723,573
-4.6% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#135
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. PFE ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
This page
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,583,636 | 2,723,573 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $80,157,195 | 2,854,601 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $60,480,406 | 2,428,932 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,012,587 | 1,923,571 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $47,802,321 | 1,972,043 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $53,934,161 | 2,128,420 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $54,880,195 | 2,068,609 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $65,998,884 | 2,280,542 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $52,259,475 | 1,867,744 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $52,960,207 | 1,908,476 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $58,558,742 | 2,033,996 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $97,431,200 | 2,937,329 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $107,392,509 | 2,927,822 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $114,880,925 | 2,815,709 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $130,946,687 | 2,555,556 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $113,442,591 | 2,592,381 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $143,636,911 | 2,739,594 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $150,117,208 | 2,899,695 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $158,378,890 | 2,682,115 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $149,970,536 | 3,486,876 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $146,415,441 | 3,738,903 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $155,832,547 | 4,301,202 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $158,549,687 | 4,307,245 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $164,878,440 | 4,492,605 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $166,268,586 | 5,084,661 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $340,466,660 | 10,430,978 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||